TITLE

Hepatitis B Vaccination and Plasma HIV-1 RNA

AUTHOR(S)
Cheeseman, Sarah H.; Davaro, Raul E.; Ellison, Richard T.
PUB. DATE
May 1996
SOURCE
New England Journal of Medicine;5/09/96, Vol. 334 Issue 19, p1272
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor about hepatitis B vaccination and HIV load in patients with moderate-to-severe HIV-related immunodeficiency is presented.
ACCESSION #
24935547

 

Related Articles

  • Letter to the Editor: Tenofovir Resistance among HIV-Infected Patients Failing a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine in a Resource-Limited Setting. Sungkanuparph, Somnuek; Manosuthi, Weerawat; Kiertiburanakul, Sasisopin; Chantratitra, Wasun // AIDS Patient Care & STDs;Oct2007, Vol. 21 Issue 10, p711 

    A letter to the editor is presented discussing the tenofovir resistance HIV-infected persons treated with a combination of drugs including Stavudine, Lamivudine, and Nevirapine.

  • Promoting Condom Availability in Schools. Clark, Margaret Pruitt; Reynolds, Jennifer Hincks // American Journal of Public Health;Apr94, Vol. 84 Issue 4, p676 

    A letter to the editor in response to Karen Hein's editorial "Getting Real" is presented.

  • Cardiovascular Disease and HIV Infection. Klein, Daniel; Hurley, Leo B.; Sidney, Stephen // New England Journal of Medicine;11/6/2003, Vol. 349 Issue 19, p1869 

    A letter to the editor is presented in response to the article "Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection," by Sam A. Bozzette, C. F. Ake, H. K. Tam, S. W. Chang, and Thomas A. Louis in the February 20, 2003 issue.

  • Cardiovascular Disease and HIV Infection. Bozzette, Sam A.; Louis, Thomas A. // New England Journal of Medicine;11/6/2003, Vol. 349 Issue 19, p1869 

    A response by Sam A. Bozzette and Thomas A. Louis to a letter to the editor about their article "Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection" in the February 20, 2003 issue is presented.

  • Expenditures for the Care of Patients with HIV. Kahn, James G. // New England Journal of Medicine;06/21/2001, Vol. 344 Issue 25, p1948 

    A letter to the editor is presented in response to the paper "Expenditures for the Care of HIV-infected Patients in the Era of Highly Active Antiretroviral Therapy," by S. A. Bozzette and colleagues, which appeared in the March 15, 2001 issue of the "New England Journal of Medicine."

  • Expenditures for the Care of Patients with HIV. Velasco, Maria; Guijarro, Carlos // New England Journal of Medicine;06/21/2001, Vol. 344 Issue 25, p1948 

    A letter to the editor is presented in response to the paper "Expenditures for the Care of HIV-infected Patients in the Era of Highly Active Antiretroviral Therapy," by S. A. Bozzette and colleagues, which appeared in the March 15, 2001 issue of the "New England Journal of Medicine."

  • Expenditures for the Care of Patients with HIV. Bozzette, Samuel A.; Joyce, Geoffrey; McCaffrey, Daniel F. // New England Journal of Medicine;06/21/2001, Vol. 344 Issue 25, p1948 

    A response by Samuel A. Bozzette and colleagues to a letter to the editor about their study "Expenditures for the Care of HIV-infected Patients in the Era of Highly Active Antiretroviral Therapy," which appeared in the March 15, 2001 issue of the "New England Journal of Medicine" is presented.

  • GB Virus C and Mortality from HIV Infection. Mosier, Donald E.; Chisari, Francis V. // New England Journal of Medicine;1/31/2002, Vol. 346 Issue 5, p377 

    A letter to the editor is presented in response to two studies on GB virus C and mortality in patients infected with human immunodeficiency virus (HIV), one by researcher Jinhua Xiang and colleagues and another by researcher Hans L. Tillmann and colleagues in the September 6, 2001 issue.

  • GB Virus C and Mortality from HIV Infection. Macalalad, Alexander R.; Snydman, David R. // New England Journal of Medicine;1/31/2002, Vol. 346 Issue 5, p377 

    A letter to the editor is presented in response to a study on GB virus C and mortality in patients infected with human immunodeficiency virus (HIV), by researcher Jinhua Xiang and colleagues in the September 6, 2001 issue.

  • GB Virus C and Mortality from HIV Infection. Takamatsu, Junki; Toyoda, Hidenori; Fukuda, Yoshihide // New England Journal of Medicine;1/31/2002, Vol. 346 Issue 5, p377 

    A letter to the editor is presented in response to two studies on GB virus C and mortality in patients infected with human immunodeficiency virus (HIV), one by researcher Jinhua Xiang and colleagues and another by researcher Hans L. Tillmann and colleagues in the September 6, 2001 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics